Clinical trial

Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy

NCT07743333

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-01

PhasePHASE4

Study timeline

Study start (actual)2024-09-01Date precision: day

Registry last updated2026-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fiberoptic Bronchoscopy (FOB)unresolved

Lung Cancer (Diagnosis)unresolved

Premedicationunresolved

Interventions

Nebulized lidocaine and ketamineDRUG

Nebulized LidocaineDRUG

Lidocaine spray (2%)DRUG

Sponsors & collaborators

Alexandria Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07743333 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.